▶주메뉴 바로가기
▶본문 바로가기
Decoded X is a weekly newsletter created by The Investor, Korea’s first and only English-based investment-related news service. It’s for the eyes of our premium readers only and will soon become a ...
Decoded X is more than just news. It's weekly brief of critical political and economic events in Korea and their takeaway, created by the The Investor staff. To ensure quality, Decoded X will soon...
DECODED X is more than just news. It’s a weekly brief of critical political and economic events in Korea and their takeaway, created by The Investor staff. To ensure content quality, DECODED X wi...
DECODED X is more than just news. It’s a weekly brief of critical political and economic events in Korea and their takeaway, created by The Investor staff. Recently, we‘ve added “Startup of the W...
DECODED X is more than just news. It’s a weekly brief of critical political and economic events in Korea and their takeaway, created by The Investor staff. Recently, we've added "Startup of the Wee...
DECODED X is more than just news. It’s a weekly brief of critical political and economic events in Korea and their takeaway, created by The Investor staff. To ensure content quality, DECODED X is...
DECODED X is more than just news. It’s a weekly brief of critical political and economic events in Korea and their takeaway, created by The Investor staff for an exclusive group of opinion leade...
DECODED X is more than just news. It’s a weekly brief of critical political and economic events in Korea and their takeaway, created by The Investor staff for an exclusive group of opinion leaders....
DECODED X is more than just news. It’s a weekly brief of critical political and economic events in Korea and their takeaway, created by The Investor staff for an exclusive group of opinion leaders. ...
Many foreign, domestic investors keen to acquire Skinfood
Kyung Nam Pharm seeks new owner
Abyo Korea hopes to redesign delivery industry
KDB forms co-investing roundtable with 6 local VCs
GenBody’s proposed IPO plans this year suffer setback
SK Biopharma signs contract with US new drug developer
Legal battle looms as approval for 1st for-profit hospital gets canceled
Mirae Asset invests in $243m mezzanine debt for grade A office building in HK
April 20, 2019
